Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease

Blood

Volumn 94, Issue 9, 1999, Pages 3022-3026

  Ware, Russell E ^a,b   Zimmerman, Sherri A ^a   Schultz, William H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; FERRITIN; HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ALLOIMMUNITY; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IRON OVERLOAD; MALE; MEAN CORPUSCULAR VOLUME; PHLEBOTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; SICKLE CELL ANEMIA; STROKE;

EID: 0033229703     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.9.3022     Document Type: Article

References (42)

1. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W: Mortality in children and adolescents with sickle cell disease. Pediatrics 84:500, 1989
2. Gray A, Anionwu EN, Davies SC, Brozovic M: Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 44:459, 1991
3. Serjeant GR: The clinical features of sickle cell disease. Baillieres Clin Haematol 6:93, 1993
4. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR: Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120:360, 1992
5. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM: Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 91:288, 1998
6. Stockman JA, Nigro MA, Mishkin MM, Oski FA: Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 287:846, 1972
7. Adams RJ, Nichols FT, McKie V, McKie K, Milner P, Gammal TE: Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI. Neurology 38:1012, 1988
8. Ohene-Frempong K: Stroke in sickle cell disease: Demographic, clinical and therapeutic considerations. Semin Hematol 28:213, 1991
9. Craft S, Schatz J, Glauser TA, Lee B, DeBaun MR: Neuropsychologic effects of stroke in children with sickle cell anemia. J Pediatr 123:712, 1993
10. Cohen MJ, Branch WB, McKie VC, Adams RJ: Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr 33:517, 1994
11. Powars D, Wilson B, Imbus C, Pegelow C, Allen J: The natural history of stroke in sickle cell disease. Am J Med 65:461, 1978
12. Russell MO, Goldberg HI, Hodson A, Kim HC, Halos J, Reivich M, Schwartz E: Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63:162, 1984
13. Milner PF: Chronic transfusion regimens in sickle cell disease. Prog Clin Biol Res 98:97, 1982
14. Piomelli S: Chronic transfusions in patients with sickle cell disease. Am J Pediatr Hematol/Oncol 7:51, 1985
15. Lusher JM, Haghighat H, Khalifa AS: A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am J Hematol 1:265, 1976
16. Russell MO, Goldberg HI, Reis L, Friedman S, Slater R, Reivich M, Schwartz E: Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J Pediatr 88:382, 1976
17. Sarnaik S, Soorya D, Kim J, Ravindranath Y, Lusher J: Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child 133:1254, 1979
18. Peglow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126:896, 1995
19. Wilimas J, Goff JR, Anderson HR Jr, Langston JW, Thompson E: Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 96:205, 1980
20. Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW, Schell MJ, Wilimas JA: High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 118:377, 1991
21. Ware RE, Steinberg MH, Kinney TR: Hydroxyurea: An alternative to transfusion therapy for stroke in sickle cell anemia. Am J Hematol 50:140, 1995
22. Marcus SJ, Kinney TR, Schultz WH, O'Branski EE, Ware RE: Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease. Am J Hematol 54:40, 1997
23. Hollander M, Wolfe D: Nonparametric Statistical Methods. New York, NY, Wiley, 1973
24. Adams DM, Schultz WH, Ware RE, Kinney TR: Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. Am J Pediatr Hematol/Oncol 18:46, 1996
25. Castellino SM, Combs MR, Zimmerman SA, Issitt PD, Ware RE: Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics, and significance. Br J Haematol 104:189, 1999
26. Noguchi CT, Rodgers GP, Serjeant GR, Schechter AN: Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med 318:96, 1988
27. Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG: Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 74:652, 1984
28. Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G Jr, Platt OS, Thomas GH: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555, 1992
29. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE: Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a Phase I/II trial. Blood, in press
30. Adragna NC, Fonseca P, Lauf PK: Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood 83:553, 1994
31. Bridges KR, Barabino GD, Brugnara C, Cho MR, Christoph GW, Dover G, Ewenstein BM, Golan DE, Guttmann CR, Hofrichter J, Mulkern RV, Zhang B, Eaton WA: A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 88:4701, 1996
32. Vichinsky EP, Lubin BH: A cautionary note regarding hydroxyurea in sickle cell disease. Blood 83:1124, 1994
33. Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, Galimberti M, Giardini C, Gazier D, Polchi P: Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Blood 90:994, 1997
34. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995
35. Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ: Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 128:820, 1996
36. Jayabose S, Tugal O, Sandoval C, Patel P, Puder D, Lin T, Visintainer P: Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. J Pediatr 129:559, 1996
37. Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E: Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial. Blood 88:1960, 1996
38. de Montalembert M, Belloy M, Bernaudin F, Gouraud F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakdjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R: Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. J Pediatr Hematol Oncol 19:313, 1997
39. Olivieri NF, Vichinsky EP: Hydroxyurea in children with sickle cell disease: Impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol 20:26, 1998
40. Rosse WF, Telen MJ, Ware RE: Transfusion support for patients with sickle cell disease. Bethesda, MD, AABB Press, 1998
41. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 326:605, 1992
42. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339:5, 1998